269 related articles for article (PubMed ID: 16792541)
21. Peripheral blood T, B, and NK cells in relation to histological hepatitis activity and fibrosis stage in chronic hepatitis C.
Panasiuk A; Prokopowicz D; Zak J; Wysocka J
Hepatogastroenterology; 2003; 50(49):178-82. PubMed ID: 12630018
[TBL] [Abstract][Full Text] [Related]
22. Chronic hepatitis C in the advanced adult and elderly subjects.
Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
[TBL] [Abstract][Full Text] [Related]
23. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
[TBL] [Abstract][Full Text] [Related]
24. Contribution of obesity to hepatitis C-related fibrosis progression.
Ortiz V; Berenguer M; Rayón JM; Carrasco D; Berenguer J
Am J Gastroenterol; 2002 Sep; 97(9):2408-14. PubMed ID: 12358265
[TBL] [Abstract][Full Text] [Related]
25. The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cells.
Schulte D; Vogel M; Langhans B; Krämer B; Körner C; Nischalke HD; Steinberg V; Michalk M; Berg T; Rockstroh JK; Sauerbruch T; Spengler U; Nattermann J
J Infect Dis; 2009 Nov; 200(9):1397-401. PubMed ID: 19780673
[TBL] [Abstract][Full Text] [Related]
26. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis.
Chrétien P; Chousterman M; Abd Alsamad I; Ozenne V; Rosa I; Barrault C; Lons T; Hagège H
J Autoimmun; 2009; 32(3-4):201-5. PubMed ID: 19324518
[TBL] [Abstract][Full Text] [Related]
27. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.
Tseng CT; Miskovsky E; Houghton M; Klimpel GR
Hepatology; 2001 May; 33(5):1312-20. PubMed ID: 11343261
[TBL] [Abstract][Full Text] [Related]
28. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.
Ward SM; Fox BC; Brown PJ; Worthington J; Fox SB; Chapman RW; Fleming KA; Banham AH; Klenerman P
J Hepatol; 2007 Sep; 47(3):316-24. PubMed ID: 17475362
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C.
Dai CY; Chuang WL; Hsieh MY; Lee LP; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
Transl Res; 2006 Sep; 148(3):128-33. PubMed ID: 16938650
[TBL] [Abstract][Full Text] [Related]
30. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury.
Bantel H; Lügering A; Heidemann J; Volkmann X; Poremba C; Strassburg CP; Manns MP; Schulze-Osthoff K
Hepatology; 2004 Nov; 40(5):1078-87. PubMed ID: 15486927
[TBL] [Abstract][Full Text] [Related]
31. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis.
Watson MW; Jaksic A; Price P; Cheng W; McInerney M; French MA; Fisher S; Lee S; Flexman JP
J Infect Dis; 2003 Nov; 188(10):1533-6. PubMed ID: 14624379
[TBL] [Abstract][Full Text] [Related]
33. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
Klade CS; Wedemeyer H; Berg T; Hinrichsen H; Cholewinska G; Zeuzem S; Blum H; Buschle M; Jelovcan S; Buerger V; Tauber E; Frisch J; Manns MP
Gastroenterology; 2008 May; 134(5):1385-95. PubMed ID: 18471515
[TBL] [Abstract][Full Text] [Related]
35. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
[TBL] [Abstract][Full Text] [Related]
36. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
37. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.
Bièche I; Asselah T; Laurendeau I; Vidaud D; Degot C; Paradis V; Bedossa P; Valla DC; Marcellin P; Vidaud M
Virology; 2005 Feb; 332(1):130-44. PubMed ID: 15661146
[TBL] [Abstract][Full Text] [Related]
38. Differential antigen specificity of hepatitis C virus-specific interleukin 17- and interferon γ-producing CD8(+) T cells during chronic infection.
Grafmueller S; Billerbeck E; Blum HE; Neumann-Haefelin C; Thimme R
J Infect Dis; 2012 Apr; 205(7):1142-6. PubMed ID: 22351943
[TBL] [Abstract][Full Text] [Related]
39. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
40. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
